Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development, manufacture, and license of orally administered controlled release drug delivery systems and products in the United States. The company focuses on developing products that cover therapeutic areas for pain, allergy, and infection. It offers two once-daily allergy products, including Lodrane 24 and Lodrane 24D. The company?s products under development comprise ELI-216, an abuse resistant oxycodone product; and ELI-154, a once-a-day oxycodone product. It also involves in contract research and development operations on behalf of other pharmaceutical companies. Elite Pha...